Mauritius has reached an important milestone in cardiovascular healthcare with the successful launch of its first Electrophysiology (EP) Programme in the public healthcare sector at Victoria Hospital. This landmark initiative represents a significant step forward in the diagnosis and treatment of cardiac arrhythmias and brings advanced, life-changing cardiac care closer to Mauritian patients.
The programme was made possible through the collaboration of HealthActiv, the distributor of Abbott cardiac rhythm management solutions in Mauritius. To support the launch and ensure the transfer of expertise, HealthActiv facilitated the visit of internationally renowned electrophysiologist Dr. Mohamed ElMaghawry from Egypt, accompanied by his experienced EP technician, Ahmed Badr. Together, they worked closely with local cardiologists, nurses, and healthcare professionals to provide hands-on training and establish a strong foundation for the future of electrophysiology in Mauritius.
Over a three-day period, the team successfully performed 16 electrophysiology procedures, including cases involving Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Atrioventricular Reentrant Tachycardia (AVRT), transseptal punctures, and catheter ablations. These procedures demonstrated both the capability of the new programme and the commitment of local healthcare teams to delivering advanced cardiac care.
Electrophysiology is a specialised field of cardiology focused on diagnosing and treating disorders of the heart's electrical system. Cardiac arrhythmias can cause symptoms such as palpitations, dizziness, shortness of breath, fatigue, and, in some cases, serious health complications. Traditionally, many patients have relied on long-term medication to manage these conditions. While medications can be effective, they may not completely eliminate symptoms and often require lifelong adherence.
One of the greatest advantages of modern electrophysiology procedures, particularly catheter ablation, is their ability to provide a long-term or permanent solution for many arrhythmias. By targeting and eliminating the abnormal electrical pathways responsible for the condition, patients can often return to a normal rhythm without the need for ongoing medication. For many individuals, this means freedom from daily drug therapy, fewer hospital visits, reduced side effects, and a significantly improved quality of life.
The impact on patients can be profound. Individuals who once experienced frequent episodes of rapid heartbeats and anxiety can return to work, participate in physical activities, travel with confidence, and enjoy a more active lifestyle. The ability to live without the constant concern of sudden arrhythmia episodes represents a major improvement in both physical and emotional well-being.
Beyond individual patient benefits, the establishment of an electrophysiology programme within the public healthcare system strengthens Mauritius' healthcare infrastructure. Patients can now access highly specialised treatment locally, reducing the need for overseas referrals and associated costs. At the same time, local healthcare professionals gain valuable expertise, ensuring that these advanced procedures become increasingly accessible to the Mauritian population.
The successful launch of the Electrophysiology Programme at Victoria Hospital marks the beginning of a promising journey for cardiac healthcare in Mauritius. Through collaboration, training, and the adoption of innovative medical technologies, Mauritian patients now have access to world-class treatment options that can transform lives and improve long-term health outcomes.
This achievement highlights what can be accomplished when healthcare professionals, industry partners, and international experts work together toward a common goal: delivering better care and a healthier future for the people of Mauritius.
